Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - TAX PROVISION
Tax Provision KALV - KalVista Pharmaceuticals, Inc.
-8.45 M
LAST VALUE
21.82%
2 YEAR CAGR
-133.33%
5 YEAR CAGR
-34.44%
10 YEAR CAGR